Keywords: pfizer, drops, diabetic, neuropathy, drug, updated, said

Pfizer drops diabetic neuropathy drug - UPDATED

Article | 18 October 2000

Pfizer has said it is suspending the development of its aldose reductaseinhibitor research candidate, zenarestat, which was being investigated for ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Pfizer

Go to company listing